Skip to main content

Anika Therapeutics(ANIK-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Current Target Price

High Target Price
Mean Target Price
Low Target Price
Median Target Price

Earnings Estimates

  Current Qtr06/2024Next Qtr09/2024Fiscal Yr12/2024Fiscal Yr12/2025
Average Estimate 0.23 0.34 1.08 1.32
Number of Estimates 1 1 1 1
High Estimate 0.23 0.34 1.08 1.32
Low Estimate 0.23 0.34 1.08 1.32
Prior Year -0.06 0.00 -0.30 1.08
Growth Rate Est. (year over year) +483.33% N/A +460.00% +22.22%

Earnings History - Surprises*

  Qtr Ending03/2024Qtr Ending12/2023Qtr Ending09/2023Qtr Ending06/2023
Reported $0.09 $0.05 $0.00 $-0.06
Estimate $0.13 $-0.15 $-0.26 $-0.27
Difference -0.04 +0.20 +0.26 +0.21
Surprise -30.77% +133.33% +100.00% +77.78%
* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.00
3 Mths Ago2
4.00
2 Mths Ago2
4.00
1 Mth Ago2
4.00
Current2

Ratings Values:

Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1

Ratings Breakdown

 3 Mths Ago2 Mths Ago1 Mth AgoCurrent
# of Analysts:2222
 
1
1
1
1
Holds1111
 

Key:

Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell

More from The Globe

Short sales on the TSX: What bearish investors are betting against
Larry MacDonald